Treating the root cause of the pain. Not the symptoms.

Instead of costly procedures, such as spinal fusion or long-term physiotherapy, our cLBP treatment is an easily performed, single injection procedure that stabilizes the disk by transforming it to connective tissue. Unlike any other currently available treatment this has the potential to permanently remove or reduce the pain significantly faster than surgical intervention.

Healthy disc

An intervertebral disc consists of two main parts: the disc centre and the wall. The disc centre consists largely of a highly hydrated gel together with nucleus pulposus cells and fibroblasts.


When a disc degenerates it becomes less stable and pro-inflammatory substances formed during the degenerative process can leak from the inner core of the disc. Pain-sensing nerves within and outside the wall of the disc are activated. These processes cause back pain.

Treated disc

By injecting a biologically active substance directly into the degenerated intervertebral disc, the cells are triggered to produce collagen and transform the damaged disc into connective tissue. This helps re-stabilize the intervertebral segment and reduces diffusion of pro-inflammatory substances.

Market outlook: 5 million treatable patients only in the US

We are currently taking the next step in our exciting journey towards an injection-based treatment for chronic low back pain. With our STA-363 treatment undergoing clinical phase 1b, we are one step closer to market.

Our market


We are participating in several conferences and industry event every year. Please do not hesitate to contact us to meet up.

Coming events
11 July 2017

Meet Stayble at NLSDays 2017-09-12

Stayble will attened NLSDays 2017. Please do not hesitate to book a meeting through the partnering platform or attend our oral presentation. For mor info visit

Read more
22 May 2017

Meet Stayble at BioEquity in Paris, 2017-05-22

Stayble will attend BioEquity in Paris. Do not hesitate to reach out to book a partnering meeting. Stayble will also present its concept during the event.

Read more

Latest news

Stay updated on our development journey

22 August 2017

Har du kronisk ländryggssmärta och vill delta i en klinisk prövning?

Vi söker Dig som lider av kronisk smärta i ländryggen och är mellan 20-60 år gammal för en läkemedelsstudie. Behandlingen innebär att Du lottas till att få en injektion med…

Read more
27 June 2017

Stayble welcomes Catharina Bäärnheilm as the chairman of the board

Catharina has a background as a pharmacist with a PhD in Pharmacogenetics and metabolism. With previous VP positions within AstraZeneca she has a great experience and network within the field….

Read more

Get in touch

We are always looking for passionate people who are interested in joining us to help realizing our vision. Please leave your contact details and we will get back to you shortly.